Company intelligence / Profile preview

Verdot

Riom, Puy-de-Dôme, Franceverdot-biotechnologies.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Provides advanced downstream purification solutions for biopharmaceutical manufacturing. Their chromatography columns and tangential flow filtration systems are used globally in the production of monoclonal antibodies, vaccines, viral vectors, and mRNA-based therapies. They have over three decades of experience in bioprocessing technology with strong international presence. No clinical results as they do not develop drugs.

Modalities: Monoclonal antibody (mAbs)VaccineViral vector (AAV and lentivirus)mRNA-based therapeuticsRecombinant protein
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Verdot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verdot.

Explore the full profile